These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 32007952)

  • 1. High expression of SMYD3 indicates poor survival outcome and promotes tumour progression through an IGF-1R/AKT/E2F-1 positive feedback loop in bladder cancer.
    Wang G; Huang Y; Yang F; Tian X; Wang K; Liu L; Fan Y; Li X; Li L; Shi B; Hao Y; Xia C; Nie Q; Xin Y; Shi Z; Ma L; Xu D; Liu C
    Aging (Albany NY); 2020 Feb; 12(3):2030-2048. PubMed ID: 32007952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulated SMYD3 promotes bladder cancer progression by targeting BCLAF1 and activating autophagy.
    Shen B; Tan M; Mu X; Qin Y; Zhang F; Liu Y; Fan Y
    Tumour Biol; 2016 Jun; 37(6):7371-81. PubMed ID: 26676636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1.
    Su F; He W; Chen C; Liu M; Liu H; Xue F; Bi J; Xu D; Zhao Y; Huang J; Lin T; Jiang C
    Cell Death Dis; 2018 Feb; 9(2):233. PubMed ID: 29445134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIB1 predicts bladder cancer outcome and promotes bladder cancer cell proliferation through AKT and E2F1.
    Tong ZT; Wei JH; Zhang JX; Liang CZ; Liao B; Lu J; Fan S; Chen ZH; Zhang F; Ma HH; Qian WC; Kong LL; Fang Y; Chen W; Xie D; Luo JH
    Br J Cancer; 2013 Apr; 108(7):1470-9. PubMed ID: 23511556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma.
    Zhu Y; Zhu MX; Zhang XD; Xu XE; Wu ZY; Liao LD; Li LY; Xie YM; Wu JY; Zou HY; Xie JJ; Li EM; Xu LY
    Hum Pathol; 2016 Jun; 52():153-63. PubMed ID: 26980013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of P3H4 inhibits proliferation and invasion of bladder cancer.
    Hao L; Pang K; Pang H; Zhang J; Zhang Z; He H; Zhou R; Shi Z; Han C
    Aging (Albany NY); 2020 Feb; 12(3):2156-2168. PubMed ID: 32018225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway.
    Wang W; Chen H; Liu Z; Qu P; Lan J; Chen H; Zou L; Qiu J
    Br J Cancer; 2016 Feb; 114(3):305-13. PubMed ID: 26742010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non‑small cell lung cancer.
    Li J; Zhao L; Pan Y; Ma X; Liu L; Wang W; You W
    Int J Oncol; 2020 Sep; 57(3):756-766. PubMed ID: 32705243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of engrailed 2 inhibits the proliferation and invasion of human bladder cancer in vitro and in vivo.
    Li Y; Liu H; Lai C; Su Z; Heng B; Gao S
    Oncol Rep; 2015 May; 33(5):2319-30. PubMed ID: 25812440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel hsa-miR-12528 regulates tumourigenesis and metastasis through hypo-phosphorylation of AKT cascade by targeting IGF-1R in human lung cancer.
    Jeon SH; Yoo JK; Kim CM; Lim ES; Lee SJ; Lee JM; Oh SH; Kim JK
    Cell Death Dis; 2018 May; 9(5):493. PubMed ID: 29712908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HOXB13 promotes gastric cancer cell migration and invasion via IGF-1R upregulation and subsequent activation of PI3K/AKT/mTOR signaling pathway.
    Guo C; Chu H; Gong Z; Zhang B; Li C; Chen J; Huang L
    Life Sci; 2021 Aug; 278():119522. PubMed ID: 33894267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA‑539 inhibits the proliferation and invasion of bladder cancer cells by regulating IGF‑1R.
    Liao G; Chen F; Zhong J; Jiang X
    Mol Med Rep; 2018 Apr; 17(4):4917-4924. PubMed ID: 29393438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of NFKBIZ affects bladder cancer progression via the PTEN/PI3K/Akt signaling pathway.
    Xu T; Rao T; Yu WM; Ning JZ; Yu X; Zhu SM; Yang K; Bai T; Cheng F
    Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33907827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
    Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR
    Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters.
    Zhang H; Zheng Z; Zhang R; Yan Y; Peng Y; Ye H; Lin L; Xu J; Li W; Huang P
    Cell Death Dis; 2021 Jul; 12(8):731. PubMed ID: 34301921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GINS1 promotes the initiation and progression of bladder cancer by activating the AKT/mTOR/c-Myc signaling pathway.
    Fu Q; Zheng H; Wang X; Tang F; Yu H; Wang H; Wan Z; Zheng Z; Yang Z; Liu T; Peng J
    Exp Cell Res; 2024 Jul; 440(1):114125. PubMed ID: 38880324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
    BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZSCAN16 promotes proliferation, migration and invasion of bladder cancer via regulating NF-kB, AKT, mTOR, P38 and other genes.
    Li X; Shang D; Shen H; Song J; Hao G; Tian Y
    Biomed Pharmacother; 2020 Jun; 126():110066. PubMed ID: 32172065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NUCKS1 promotes gastric cancer cell aggressiveness by upregulating IGF-1R and subsequently activating the PI3K/Akt/mTOR signaling pathway.
    Huang YK; Kang WM; Ma ZQ; Liu YQ; Zhou L; Yu JC
    Carcinogenesis; 2019 Apr; 40(2):370-379. PubMed ID: 30371738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of SMYD3 by RNA interference down-regulates c-Met expression and inhibits cells migration and invasion induced by HGF.
    Zou JN; Wang SZ; Yang JS; Luo XG; Xie JH; Xi T
    Cancer Lett; 2009 Jul; 280(1):78-85. PubMed ID: 19321255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.